These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33247595)

  • 1. Determination of PEGylation homogeneity of polyethylene glycol-modified canine uricase.
    Li H; Huo J; Sun D; Guo Y; Jiang L; Zhang H; Shi X; Zhao Z; Zhou J; Hu C; Zhang C
    Electrophoresis; 2021 Mar; 42(6):693-699. PubMed ID: 33247595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization, efficacy, pharmacokinetics, and biodistribution of 5kDa mPEG modified tetrameric canine uricase variant.
    Zhang C; Fan K; Luo H; Ma X; Liu R; Yang L; Hu C; Chen Z; Min Z; Wei D
    Int J Pharm; 2012 Jul; 430(1-2):307-17. PubMed ID: 22503989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of large aggregated uricases and PEG diol on accelerated blood clearance of PEGylated canine uricase.
    Zhang C; Fan K; Ma X; Wei D
    PLoS One; 2012; 7(6):e39659. PubMed ID: 22745806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of Polyethylene Glycol-Modified Canine Uricase Following Single and Multiple Intravenous Injections in Cynomolgus Monkeys.
    Li H; Huo J; Sun D; Jiang L; Hu C; Bai Y; Ma X; Zhang H; Shi X; Zhao Z; Zhou J; Lu Y; Zhang C
    Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):445-451. PubMed ID: 32162270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and provides an alternative to HPLC in characterization of protein PEGylation.
    Zheng C; Ma G; Su Z
    Electrophoresis; 2007 Aug; 28(16):2801-7. PubMed ID: 17702059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary electrophoretic separation of poly(ethylene glycol)-modified granulocyte-colony stimulating factor.
    Lee KS; Na DH
    Arch Pharm Res; 2010 Mar; 33(3):491-5. PubMed ID: 20361316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach enables imaged capillary isoelectric focusing analysis of PEGylated proteins.
    Zhang X; Chemmalil L; Ding J; Li Z
    Electrophoresis; 2020 May; 41(9):735-742. PubMed ID: 31967659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
    Kurfürst MM
    Anal Biochem; 1992 Feb; 200(2):244-8. PubMed ID: 1378701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification with polysialic acid-PEG copolymer as a new method for improving the therapeutic efficacy of proteins.
    Wu J; Lu S; Zheng Z; Zhu L; Zhan X
    Prep Biochem Biotechnol; 2016 Nov; 46(8):788-797. PubMed ID: 26829568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylation enhancement of pH stability of uricase via inhibitive tetramer dissociation.
    Tian H; Guo Y; Gao X; Yao W
    J Pharm Pharmacol; 2013 Jan; 65(1):53-63. PubMed ID: 23215688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extension arm facilitated PEGylation of hemoglobin: correlation of the properties with the extent of PEGylation.
    Li D; Manjula BN; Acharya AS
    Protein J; 2006 Jun; 25(4):263-74. PubMed ID: 16718519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of modification of a bacterial uricase with N-hydroxysuccinimide esters of succinate and carbonate of monomethoxyl poly(ethylene glycol).
    Zhang C; Yang X; Gao A; Hu X; Pu J; Liu H; Feng J; Liao J; Li Y; Liao F
    Biotechnol Appl Biochem; 2014; 61(6):683-90. PubMed ID: 24512141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of yeast uricase with polyethylene glycol: disappearance of binding ability towards anti-uricase serum.
    Nishimura H; Ashihara Y; Matsushima A; Inada Y
    Enzyme; 1979; 24(4):261-4. PubMed ID: 573687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase.
    Tsuji J; Hirose K; Kasahara E; Naitoh M; Yamamoto I
    Int J Immunopharmacol; 1985; 7(5):725-30. PubMed ID: 2412977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of pegylated proteins.
    Fee CJ; Van Alstine JM
    Methods Biochem Anal; 2011; 54():339-62. PubMed ID: 21954785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of extent of PEGylation using denaturing capillary isoelectric focussing.
    Minshull TC; Wood A; Roberts D; Hallam C; Lewis J; Orekoya A; Gervais D
    Anal Biochem; 2020 Dec; 611():113953. PubMed ID: 32946834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals.
    Natarajan A; Xiong CY; Albrecht H; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2005; 16(1):113-21. PubMed ID: 15656582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species and sex differences in the blood clearance and immunogenicity of PEGylated uricase: A comparative 26-week toxicity study in rats and monkeys.
    Zhang C; Fan K; Luo H; Cheng Y; Lu Y; Zheng J; Chen Z; Xue J; Zhao Q; Zhang M; Ge Y; Hu C; Bai Y; Yang L; Ma X; Chen M; Zhao Z; Shi X
    Life Sci; 2020 Aug; 255():116892. PubMed ID: 31610209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
    Ganson NJ; Kelly SJ; Scarlett E; Sundy JS; Hershfield MS
    Arthritis Res Ther; 2006; 8(1):R12. PubMed ID: 16356199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A PEGylation technology of L-asparaginase with monomethoxy polyethylene glycol-propionaldehyde.
    Wang B; Cao Y; Chi S; Lou D
    Z Naturforsch C J Biosci; 2012; 67(5-6):312-8. PubMed ID: 22888537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.